Page 29 - Journal of Special Operations Medicine - Spring 2014
P. 29

a.  Able to fight:                               Tactical Field Care
                  These medications should be carried by the com-  Analgesia on the battlefield should generally be achieved
                   batant and self-administered as soon as possible   using one of three options:
                   after the wound is sustained.
                   –  Mobic, 15mg PO once a day                  1.  Mild to Moderate Pain
                   –   Tylenol, 650mg bilayer caplet, 2 PO every 8      Casualty is still able to fight
                     hours
                b.   Unable  to  fight:  (Note:  Have  naloxone  readily   TCCC Combat Pill Pack:
                                                                   Tylenol – 650mg bilayer caplet, 2 PO every 8 hours
                   available whenever administering opiates.)      Meloxicam – 15mg PO once a day
                   –   Does not otherwise require IV/IO access   2.  Moderate to Severe Pain
                   –   Oral transmucosal fentanyl citrate (OTFC),      Casualty IS NOT in shock or respiratory distress
                     800µg transbucally                                               AND
                     •  Recommend taping lozenge-on-a-stick to ca-     Casualty IS NOT at significant risk of developing ei-
                       sualty’s finger as an added safety measure
                     •  Reassess in 15 minutes                     ther condition
                                                                   –   Oral transmucosal fentanyl citrate (OTFC) 800µg
                     •  Add second lozenge, in other cheek, as neces-  –   Place lozenge between the cheek and the gum
                       sary to control severe pain
                                                                   –   Do not chew the lozenge
                     •  Monitor for respiratory depression       3.  Moderate to Severe Pain
                                    OR
                   –   Ketamine 50–100mg IM                         Casualty IS in hemorrhagic shock or respiratory distress
                                                                                       OR
                     •  Repeat dose every 30 minutes to 1 hour as      Casualty IS at significant risk of developing either
                       necessary to control severe pain or until the   condition
                       casualty develops nystagmus (rhythmic eye   –  Ketamine 50mg IM or IN
                       movement back and forth)                                        OR
                                    OR
                   –   Ketamine 50mg intranasal (using nasal atom-  –  Ketamine 20mg slow IV or IO

                                                                      *Repeat doses q30min prn for IM or IN
                     izer device)                                     *Repeat doses q20min prn for IV or IO
                     •  Repeat dose every 30 minutes to 1 hour as        *End points: Control of pain or development of
                       necessary to control severe pain or until the   nystagmus (rhythmic back-and-forth movement
                       casualty develops nystagmus
                                                                      of the eyes)
                                                                 *Analgesia notes
                IV or IO access obtained:                        1.  Casualties may need to be disarmed after being given
                   –   Morphine sulfate, 5mg IV/IO                 OTFC or ketamine.
                     •  Reassess in 10 minutes.                  2.  Document  a mental  status exam  using the  AVPU
                     •  Repeat dose every 10 minutes as necessary to   method prior to administering opioids or ketamine.
                       control severe pain.
                     •  Monitor for respiratory depression       3.  For all casualties given opiods or ketamine – monitor
                                                                   airway, breathing, and circulation closely
                                    OR
                   –  Ketamine 20mg slow IV/IO push over 1 minute  4.  Directions for administering OTFC:
                                                                   –   Recommend taping lozenge-on-a-stick to casu-
                     •  Reassess in 5–10 minutes.                     alty’s finger as an added safety measure OR uti-
                     •  Repeat dose every 5–10 minutes as necessary   lizing a safety pin and rubber band to attach the
                       to control severe pain or until the casualty   lozenge (under tension) to the casualty’s uniform
                       develops nystagmus
                                                                      or plate carrier.
                     •  Continue to monitor for respiratory depres-  –   Reassess in 15 minutes
                       sion and agitation
                   –   Promethazine, 25mg IV/IM/IO every 6 hours   –   Add second lozenge, in other cheek, as necessary
                                                                      to control severe pain
                     as needed for nausea or for synergistic analge-  –   Monitor for respiratory depression
                     sic effect
                                                                 5.  IV Morphine is an alternative to OTFC if IV access
                                                                   has been obtained
                   *Note: Narcotic analgesia should be avoided in   –   5mg IV/IO
                    casualties  with respiratory  distress,  decreased   –   Reassess in 10 minutes.
                    oxygen saturation, shock, or decreased level of   –   Repeat dose every 10 minutes as necessary to con-
                    consciousness.
                                                                      trol severe pain.
                                                                   –   Monitor for respiratory depression
              Proposed Change                                    6.  Naloxone (0.4mg IV/IN/IM) should be available
              New wording – Red text denotes new material
                                                                   when using opioid analgesics.


              Triple-Option Analgesia Plan for TCCC                                                           21
   24   25   26   27   28   29   30   31   32   33   34